Read More Pharma Industry News Will intravenous oncolytic viruses finally overcome metastatic delivery barriers? ViroMissile, Inc. expands IDOV-Immune into U.S. cancer centers after FDA IND clearance. Explore what this means for systemic viral oncology. bySoujanya RaviFebruary 20, 2026